Graves’ Disease: The Antibody-Hormone Signature in Bloodwork

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Graves' disease testing measures TSH (typically suppressed below 0.4), free T4 (elevated above ~1.8), and antibodies—TPO, Tg, and TSH-receptor antibodies (TRAb/TSI)—to confirm autoimmune-driven hyperthyroidism. Suppressed TSH is associated with palpitations, atrial fibrillation risk, and bone loss. Pairing hormone levels with antibody status may help support monitoring across cardiovascular, bone, reproductive, and ophthalmic systems.

Read more →

Understand what your thyroid health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Graves' disease and the antibody-hormone signature

Graves’ disease biomarkers are blood clues that show two things: how fast the thyroid engine is running and what’s pressing the gas pedal. The hallmark is antibodies against the thyroid’s on-switch, the TSH receptor (TSH receptor antibodies, TRAb; thyrotropin receptor antibodies). The stimulating type (thyroid-stimulating immunoglobulins, TSI) binds this receptor and continuously tells the gland to release hormone. Detecting these antibodies confirms an autoimmune driver and helps distinguish Graves’ disease from other causes of an overactive thyroid. Hormone measures—thyroxine and triiodothyronine (free T4 and T3)—show how much thyroid signal is reaching the body, while the pituitary messenger (thyroid-stimulating hormone, TSH) reflects the brain’s feedback to the gland. Read together, these markers map cause and effect: an immune signal pushing the receptor, a gland producing hormone, and the body responding. Because the same receptor is present in tissues around the eyes, these antibodies also connect the thyroid process to eye symptoms in Graves’ orbitopathy. In short, Graves’ biomarkers turn symptoms into a clear, objective picture that guides diagnosis, monitoring, and treatment.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why a thyroid-plus-antibody panel matters in suspected Graves'

Graves’ disease turns the thyroid’s “metabolic throttle” too high, speeding the heart, burning energy, and amplifying brain, muscle, bone, and reproductive signals. Blood tests quantify that throttle and identify the autoimmune driver, letting us see how far the whole system has shifted and which organs are at risk. For most people, TSH sits around 0.4–4 and free T4 around 0.8–1.8, with “feel-best” values often near the middle. In Graves’, TSH is typically suppressed and free T4 rises. Thyroid peroxidase antibodies (TPO Ab) and thyroglobulin antibodies (Tg Ab) are ideally negative or as low as possible; when elevated, they mark thyroid autoimmunity. Graves‑specific TSH receptor antibodies (TRAb/TSI), when present, point to active, stimulating autoimmunity and help forecast eye involvement and pregnancy risks. When values go low in the pituitary signal, a very low TSH means the brain senses too much thyroid hormone. People often notice pounding or irregular heartbeats, anxiety, tremor, heat intolerance, unintended weight loss, diarrhea, and sleep disruption; women may have lighter or irregular periods and reduced fertility, men can lose muscle and libido, and older adults are prone to atrial fibrillation and heart failure. If free T4 falls below range (for example during overtreatment), the body shifts toward slowness—fatigue, cold sensitivity, constipation, and depressed mood. When hormones run high, a high free T4 confirms overt hyperthyroidism; persistently high antibodies signal ongoing immune activation, even if symptoms ebb. Big picture: these biomarkers map how thyroid autoimmunity intersects with the heart, brain, bone, metabolism, eyes, and pregnancy. Tracking them links day‑to‑day symptoms to long‑term risks such as arrhythmias, bone loss, and adverse pregnancy outcomes, guiding safe monitoring over time.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

What blood tests reveal about Graves' — and where they stop

Graves’ disease blood testing provides a window into how your thyroid system is functioning, which is central to energy production, metabolism, heart rhythm, cognitive clarity, reproductive health, and immune balance. At Superpower, we assess four key biomarkers: TSH (thyroid-stimulating hormone), free T4 (free thyroxine), TPO Ab (thyroid peroxidase antibodies), and Tg Ab (thyroglobulin antibodies). Together, these markers help us understand the underlying activity and stability of your thyroid and immune systems. TSH is a hormone produced by the pituitary gland that signals the thyroid to make hormones. In Graves’ disease, the immune system mistakenly stimulates the thyroid, often causing TSH to drop below normal while free T4 rises above normal. Free T4 is the main active thyroid hormone circulating in your blood, directly influencing how your body uses energy. TPO Ab and Tg Ab are antibodies that reflect immune system activity against thyroid proteins; their presence supports the diagnosis of autoimmune thyroid disease, including Graves’ Disease. When TSH is low and free T4 is high, it suggests the thyroid is overactive (hyperthyroidism), which can disrupt metabolic stability, heart function, and mental focus. Elevated TPO Ab and Tg Ab indicate ongoing immune involvement, which can affect the long-term health and resilience of the thyroid system. Interpretation of these biomarkers can be influenced by factors such as pregnancy, age, acute illness, certain medications, and differences in laboratory methods. These variables are important to consider for an accurate understanding of your thyroid health.

Frequently Asked Questions

References

  1. Smith TJ, Hegedüs L (2016). Graves' disease. *New England Journal of Medicine*, *375*(16), 1552-1565. https://doi.org/10.1056/NEJMra1510030
  2. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA (2016). 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. *Thyroid*, *26*(10), 1343-1421. https://doi.org/10.1089/thy.2016.0229
  3. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002). Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). *The Journal of Clinical Endocrinology & Metabolism*, *87*(2), 489-499. https://doi.org/10.1210/jcem.87.2.8182
  4. Ralli M, Angeletti D, Fiore M, D'Aguanno V, Lambiase A, Artico M, de Vincentiis M, Greco A (2020). Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. *Autoimmunity Reviews*, *19*(10), 102649. https://doi.org/10.1016/j.autrev.2020.102649
  5. Mayo Clinic. (n.d.). *Graves' disease - Symptoms and causes*. https://www.mayoclinic.org/diseases-conditions/graves-disease/symptoms-causes/syc-20356240

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$349

/year*

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.96 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/biomarkers.